Urinary Bladder Neoplasms: all 1,649 studies

Page 6 of 17. Open to participants first (427), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)CompletedNCT03474107Phase 3Results posted
• A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)Active, not recruitingNCT03459846Phase 2Results posted
• Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary TractCompletedNCT03430895Phase 2Results posted
• Rucaparib in Patients With Locally Advanced or Metastatic Urothelial CarcinomaTerminatedNCT03397394Phase 2Results posted
• Project HERO: Health Empowerment & Recovery OutcomesCompletedNCT03345563Not applicableResults posted
• Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical CystectomyCompletedNCT03319745Phase 2Results posted
• BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing CystectomyCompletedNCT03294304Phase 2Results posted
• Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)CompletedNCT03258593Phase 1Results posted
• Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or LymphomaCompletedNCT03229278Phase 1Results posted
• A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT)TerminatedNCT03224182Phase 3Results posted
• A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder CancerCompletedNCT03219333Phase 2Results posted
• Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)TerminatedNCT03167151Phase 1/2Results posted
• Investigation of Sugammadex in Outpatient Urological ProceduresCompletedNCT03138967Phase 4Results posted
• MAGE-A4ᶜ¹º³²T for Multi-TumorActive, not recruitingNCT03132922Phase 1Results posted
• TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder CancerCompletedNCT03125226Not applicableResults posted
• Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) ExpressionTerminatedNCT03125200Phase 1Results posted
• Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder CancerCompletedNCT03081858Phase 1/2Results posted
• Comparison of Obturator Nerve Blockade and Neuromuscular BlockadeCompletedNCT03063255Phase 4Results posted
• Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder CancerCompletedNCT03063125Results posted
• Near Infrared Fluorescence Imaging for Bladder Cancer DetectionCompletedNCT03058705Not applicableResults posted
• Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 MutationsActive, not recruitingNCT03047213Phase 2Results posted
• Neuromuscular Blockade During Transurethral Resection of Bladder CancerCompletedNCT03039543Phase 4Results posted
• A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)CompletedNCT02951767Phase 2Results posted
• Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid TumorsCompletedNCT02903914Phase 1Results posted
• Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the BladderTerminatedNCT02901548Phase 2Results posted
• Steps to Eliminate Postoperative ProblemsCompletedNCT02880176Not applicableResults posted
• Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder CancerCompletedNCT02808143Phase 1Results posted
• Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) ParticipantsTerminatedNCT02792192Phase 1/2Results posted
• Genomic Based Assignment of Therapy in Advanced Urothelial CarcinomaCompletedNCT02788201Phase 2Results posted
• ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)CompletedNCT02773849Phase 3Results posted
• Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710CompletedNCT02756637Results posted
• Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder CancerTerminatedNCT02716896Not applicableResults posted
• The Bladder Instillation Comparison StudyCompletedNCT02695771Phase 3Results posted
• Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant TherapyCompletedNCT02690558Phase 2Results posted
• Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder CancerCompletedNCT02662062Phase 2Results posted
• BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the BladderCompletedNCT02657486Not applicableResults posted
• Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced CholangiocarcinomaCompletedNCT02631590Phase 2Results posted
• Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell CarcinomaCompletedNCT02619253Phase 1Results posted
• LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial CancerTerminatedNCT02612194Phase 2Results posted
• Enzalutamide for Bladder Cancer ChemopreventionTerminatedNCT02605863Phase 2Results posted
• A Study of Intravesical Apaziquone as a Surgical Adjuvant in Participant Undergoing Transurethral Resection Bladder Tumor (TURBT)TerminatedNCT02563561Phase 3Results posted
• A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance SettingCompletedNCT02560584Phase 3Results posted
• Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder CancerTerminatedNCT02560038Phase 2Results posted
• Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)CompletedNCT02553642Phase 2Results posted
• Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsCompletedNCT02552121Phase 1/2Results posted
• Study of Tremelimumab in Patients With Advanced Solid TumorsCompletedNCT02527434Phase 2Results posted
• Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder CancerCompletedNCT02500121Phase 2Results posted
• Comparison of Nerve Stimulating Approach and Interfascial Injection Approach During Sono-guided Obturator Nerve BlockCompletedNCT02452944Not applicableResults posted
• Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCGCompletedNCT02449239Phase 3Results posted
• Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC SubjectsCompletedNCT02365766Phase 1/2Results posted
• Intravesical BCG Administration to Patients With Invasive Bladder CancerTerminatedNCT02365207Not applicableResults posted
• Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical CystectomyCompletedNCT02355886Phase 2/3Results posted
• MK-3475/BCG in High Risk Superficial Bladder CancerCompletedNCT02324582Phase 1Results posted
• Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid TumorsCompletedNCT02318329Phase 1Results posted
• Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder CancerTerminatedNCT02316548Phase 2Results posted
• CAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON)CompletedNCT02316171Phase 1Results posted
• A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]CompletedNCT02302807Phase 3Results posted
• Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder CancerCompletedNCT02300610Phase 1Results posted
• Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder CancerCompletedNCT02281383Phase 2Results posted
• Propofol and Sevoflurane for Catheter-Related Bladder DiscomfortCompletedNCT02252445Not applicableResults posted
• Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder CancerCompletedNCT02240238Phase 1/2Results posted
• Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and SurvivorsCompletedNCT02233842Results posted
• Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral ResectionTerminatedNCT02202044Not applicableResults posted
• Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder TumorsCompletedNCT02197897Phase 2Results posted
• S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder CancerCompletedNCT02177695Phase 2Results posted
• Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing SurgeryTerminatedNCT02169284Phase 2Results posted
• Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant ChemotherapyTerminatedNCT02145390Not applicableResults posted
• Afatinib in Advanced Refractory Urothelial CancerTerminatedNCT02122172Phase 2Results posted
• A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)CompletedNCT02108652Phase 2Results posted
• Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose CisplatinTerminatedNCT02030574Phase 2Results posted
• Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced MalignanciesCompletedNCT02030067Phase 1/2Results posted
• Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCGCompletedNCT02015104Phase 2Results posted
• A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBTTerminatedNCT02010203Phase 1/2Results posted
• Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder CancerCompletedNCT02009332Phase 1/2Results posted
• Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsCompletedNCT02001623Phase 1/2Results posted
• Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder CancerCompletedNCT01938573Phase 1/2Results posted
• Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder CancerTerminatedNCT01916109Phase 2Results posted
• Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder CancerCompletedNCT01827943Phase 2Results posted
• Study of Weekly Radiotherapy for Bladder CancerCompletedNCT01810757Not applicableResults posted
• Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder CancerCompletedNCT01780545Phase 2Results posted
• Cabozantinib for Advanced Urothelial CancerCompletedNCT01688999Phase 2Results posted
• Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder CancerCompletedNCT01687244Phase 2Results posted
• Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II DiabetesCompletedNCT01637935Results posted
• Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial CancerCompletedNCT01631552Phase 1/2Results posted
• A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder CancerTerminatedNCT01625260Phase 1/2Results posted
• Bristol Bladder TrialCompletedNCT01616875Phase 2Results posted
• Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder CancerTerminatedNCT01611662Phase 2Results posted
• Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder CancerCompletedNCT01589094Phase 2Results posted
• PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder TumorsCompletedNCT01567462Not applicableResults posted
• Adjuvant Proton Therapy or IMRT for the Treatment of Bladder CancerCompletedNCT01520038Phase 1/2Results posted
• A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder CancerTerminatedNCT01495676Not applicableResults posted
• Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer TreatmentCompletedNCT01489813Phase 2Results posted
• Imaging Study for FdCyd and THU Cancer TreatmentTerminatedNCT01479348Early Phase 1Results posted
• Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)TerminatedNCT01469221Phase 3Results posted
• Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaCompletedNCT01444456Results posted
• Safety and Efficacy Study of MAGE-A3 + AS-15 in Patients With Muscle-invasive Bladder Cancer After CystectomyTerminatedNCT01435356Phase 2Results posted
• Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder CancerTerminatedNCT01410565Phase 3Results posted
• Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in BladderTerminatedNCT01382706Phase 2Results posted
• Oral Lenalidomide and Intravesical BCG for Therapy of Bladder CancerCompletedNCT01373294Phase 2Results posted
• Gemcitabine, Cisplatin, Plus Lenalidomide as First-line Therapy for Patients With Metastatic Urothelial CarcinomaTerminatedNCT01342172Phase 1/2Results posted

← Urinary Bladder Neoplasms overview